Rodeo Therapeutics
Seattle
About Rodeo Therapeutics
Rodeo Therapeutics is a drug development company focused on novel enzyme target and biological pathway that play a critical role in tissue repair and regeneration. Rodeo’s initial goal is to develop novel small molecules therapies for the treatment of inflammatory bowel disease and the promotion of blood cell reconstitution following bone marrow transplant.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $14.8M
- Funding stage: M&A
- Last round: Series Unknown (Nov 2018)
- Website: rodeotherapeutics.com
- Phone: (206)957-7300
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/rodeo-therapeutics-120950 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.